Corey A. Siegel, MD Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center/Dartmouth Medical School, Lebanon, NH
Arief A. Suriawinata, MD Department of Pathology, Dartmouth-Hitchcock Medical Center/Dartmouth Medical School, Lebanon, NH
Anne M. Silas, MD Department of Radiology, Dartmouth-Hitchcock Medical Center/Dartmouth Medical School, Lebanon, NH
Dirk J. Van Leeuwen, MD, PhD Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center/Dartmouth Medical School, Lebanon, NH
Address: Dirk J. van Leeuwen, MD, PhD, Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756
ABSTRACTClinical imaging and serologic testing are increasingly replacing biopsy for diagnosing hepatic diseases. However, more biopsies are being done to stage and grade hepatitis C and fatty liver disease, to diagnose space-occupying lesions (typically with fine-needle aspiration biopsy), and to assess response to therapy. If biopsy is planned, it is important to evaluate its indications and risks and, if other physicians are involved, who is responsible for what.